Cargando…
Investigating the hepatitis B virus life cycle using engineered reporter hepatitis B viruses
Chronic infection with hepatitis B virus (HBV) increases the risk of developing fibrosis, cirrhosis or hepatocellular carcinoma. Current therapies are limited to type‐I interferons and/or nucleos(t)ide analogues; however, these are only partially effective. The development of novel anti‐HBV agents f...
Autores principales: | Nishitsuji, Hironori, Harada, Keisuke, Ujino, Saneyuki, Zhang, Jing, Kohara, Michinori, Sugiyama, Masaya, Mizokami, Masashi, Shimotohno, Kunitada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765299/ https://www.ncbi.nlm.nih.gov/pubmed/29121422 http://dx.doi.org/10.1111/cas.13440 |
Ejemplares similares
-
Novel reporter system to monitor early stages of the hepatitis B virus life cycle
por: Nishitsuji, Hironori, et al.
Publicado: (2015) -
Orchestration of Intracellular Circuits by G Protein-Coupled Receptor 39 for Hepatitis B Virus Proliferation
por: Goto, Kaku, et al.
Publicado: (2020) -
Modulation of hepatitis B virus infection by epidermal growth factor secreted from liver sinusoidal endothelial cells
por: Chen, Shin-Wei, et al.
Publicado: (2020) -
Engineering Cellular Biosensors with Customizable Antiviral Responses Targeting Hepatitis B Virus
por: Matsunaga, Satoko, et al.
Publicado: (2020) -
Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus
por: Kaneko, Shun, et al.
Publicado: (2016)